Le Lézard
Classified in: Health, Business
Subjects: TNM, JVN

Anchor Health Properties Acquires Three Class A East Coast Medical Office Buildings With Morgan Stanley


CHARLOTTESVILLE, Va., April 17, 2018 /PRNewswire/ -- Anchor Health Properties has formed a joint venture with a Morgan Stanley Real Estate Investing advised fund for the purpose of acquiring three medical office buildings on the East Coast during the first quarter of 2018.  The joint venture is complementary to investments made through Anchor's existing flagship acquisitions joint venture with the Carlyle Group, as well as its discretionary commingled and comanaged fund Chestnut Healthcare Partners. 

Anchor Health Properties Chief Executive Officer Ben Ochs said of the new joint venture investments, "establishing this joint venture has allowed us to acquire three best-in-class investments in two of the highest profile US markets, with a very long-term investment mindset.  The joint venture investments are a good complement to our existing successful investment programs, which also continue to grow rapidly and perform well with our existing investment partners.  We are fortunate to be able to work with some of the strongest and most well-respected equity capital partners in the world and hope to grow all of our investment relationships in the future."

The joint venture closed on two Class A medical office buildings that reside on the campus of Doylestown Hospital in suburban Philadelphia totaling nearly 150,000 square feet.  Doylestown Hospital leases the majority of the space on long term leases.  The joint venture also closed on an approximately 100,000 square foot Class A campus adjacent medical office building in Matthews, North Carolina, which sits next to Novant Health's Matthews Hospital campus.  The fully leased Adbel Plaza building is primarily leased to Novant Health, with some additional space leased to Atrium Health. 

Anchor Chief Investment Officer James Schmid noted, "the acquisition closing of the three joint venture assets represents the acquisition of best-in-class real estate in two highly desirable primary markets where Anchor has a strong existing presence.  The core profile and health system anchor tenancy of each investment helps drive long term occupancy and stability of cashflow.  We are excited to continue to expand our relationships with Doylestown Hospital and Novant Health, and our footprint in the Philadelphia and Charlotte medical real estate markets."

About Anchor Health Properties
Anchor Health Properties is a full-service development, management, leasing, and investment platform serving investors and health systems across the United States.  Anchor manages and leases nearly four million square feet of medical office space, inclusive of numerous projects under construction.  Anchor maintains ten offices nationally (including new offices in Charlotte, metro New York City, and Denver, resulting from recent acquisitions) and features nearly 50 professionals in its ranks.  Over the past five years, Anchor principals have acquired and/or developed over $3billion of medical real estate across the country. For more information, please visit: www.anchorhealthproperties.com.

Contact: Rachael Osberger, Anchor Health Properties
[email protected]; 302-655-1010

SOURCE Anchor Health Properties


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: